News
Stories about the companies we track, gathered daily from UK and European tech press and Google News. Headlines link to the original publisher.
8 storiesCytospire Therapeutics ✕
Clear all- LeadershipBioSpace, 8 Sept 2026Cytospire Therapeutics Appoints Highly Experienced Immuno-Oncology Leader, Sumeet Ambarkhane, M.D., as Chief Medical Officer
- OtherServier, 12 May 2026Servier Ventures selects Cytospire Therapeutics for its first investment
- OtherBioCentury, 6 May 2026Cytospire: Broadening tumor killing with pan-γδ T cell engagers
- OtherGlobeNewswire, 5 May 2026Cytospire Therapeutics announces oversubscribed £61 million
- OtherOncodaily, 5 May 2026$83M to Unlock a New Generation of Cancer Immunotherapies – Cytospire Therapeutics Ltd
- OtherFirstWord, 5 May 2026Cytospire banks £61M to test pan-gamma delta engager approach for cancer
- FundingEuropean Biotechnology Magazine, 5 May 2026Cytospire raises £61M to take gamma-delta T-cell engager into the clinic
- Otherpharmaphorum, 5 May 2026UK's Cytospire draws in $83m for new T-cell engager platform